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How is the cochlear clock regulated?
Cederroth, Park et al. show that circadian
rhythms in the cochlea are controlled by
the suprachiasmatic nucleus and
glucocorticoids from the adrenal glands
that act as major regulators of the
differential sensitivity to day and night
noise trauma.
Current Biology
ArticleCircadian Regulation of Cochlear Sensitivity
to Noise by Circulating Glucocorticoids
Christopher R. Cederroth,1,8,9,* Jung-sub Park,1,6,8 Vasiliki Basinou,1,8 Benjamin D. Weger,4 Evangelia Tserga,1
Heela Sarlus,1 Anna K. Magnusson,2 Nadir Kadri,3 Frederic Gachon,4,5,7 and Barbara Canlon1
1Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden
2Department of Clinical Science Intervention and Technology, Karolinska Institutet, Stockholm 17177, Sweden
3Department of Laboratory Medicine, Karolinska Institutet, Stockholm 17177, Sweden
4Department of Diabetes and Circadian Rhythms, Nestle Institute of Health Sciences, 1015 Lausanne, Switzerland
5School of Life Sciences, Ecole Polytechnique Federale de Lausanne, 1015 Lausanne, Switzerland
6Department of Otolaryngology, Ajou University School of Medicine, 164, Worldcup-ro, Yeongtong-gu, Suwon 16499, Korea
7Present address: Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia




The cochlea possesses a robust circadian clock ma-
chinery that regulates auditory function. How the
cochlear clock is influenced by the circadian system
remains unknown. Here, we show that cochlear
rhythms are system driven and require local Bmal1
as well as central input from the suprachiasmatic
nuclei (SCN). SCN ablations disrupted the circadian
expression of the core clock genes in the cochlea.
Because the circadian secretion of glucocorticoids
(GCs) is controlled by the SCN and GCs are known
to modulate auditory function, we assessed their in-
fluence on circadian gene expression. Removal of
circulating GCs by adrenalectomy (ADX) did not
have a major impact on core clock gene expression
in the cochlea. Rather it abolished the transcription
of clock-controlled genes involved in inflammation.
ADX abolished the known differential auditory sensi-
tivity to day and night noise trauma and prevented
the induction of GABA-ergic and glutamate receptors
mRNA transcripts. However, these improvements
were unrelated to changes at the synaptic level, sug-
gesting other cochlear functions may be involved.
Due to this circadian regulation of noise sensitivity
by GCs, we evaluated the actions of the synthetic
glucocorticoid dexamethasone (DEX) at different
times of the day. DEX was effective in protecting
from acute noise trauma only when administered
during daytime, when circulating glucocorticoids
are low, indicating that chronopharmacological
approaches are important for obtaining optimal treat-
ment strategies for hearing loss. GCs appear as ama-
jor regulator of the differential sensitivity to day or
night noise trauma, a mechanism likely involving the
circadian control of inflammatory responses.Current Biology 29, 2477–2487, Aug
This is an open access article undINTRODUCTION
Disruptions in the regulation of circadian rhythms are known to
affect a large number of bodily functions, including sleep, meta-
bolism, and inflammatory responses [1]. The mammalian circa-
dian clock system is organized hierarchically with the bilateral
suprachiasmatic nuclei (SCN) of the hypothalamus being the
master clock that orchestrates physiological functions of all pe-
ripheral organs through neuroendocrine and autonomic nervous
systems [2, 3]. When the SCN is ablated, oscillations in periph-
eral tissues become asynchronous [4]. Although light is the
main synchronizer of the SCN clock, other cues, like feeding, lo-
comotor activity, temperature, and hormonal factors, can syn-
chronize peripheral clocks. Hormones under strict circadian
control, such as glucocorticoids (GCs), have been shown to
entrain peripheral organs [3, 5] and become arrhythmic in the
absence of the SCN [6–9]. GCs are among the most potent syn-
chronizers of peripheral clocks [10, 11] through interactions with
the core clock proteins [12, 13].
The core clock system consists of autoregulatory transcrip-
tional and translational feedback loops that regulate clock-
controlled genes for specific physiological outputs [1]. Disruption
of clock genes (Per,Cry,Clock,Bmal1,Rev-erb, andRor) in mice
is known to generate a variety of phenotypes [14]. In particular,
disruption of Bmal1 has the greatest impact on clock rhythms
and mutants lacking Bmal1 display a wide array of disorders,
including arrhythmic locomotor activity in constant darkness
[15], arthropathy [16], infertility [17, 18], symptoms of the meta-
bolic syndrome [19, 20], reduced B cell production [21], and
decreased lifespan [22], overall highlighting its important role
for the maintenance of homeostasis.
Recently, a robust self-sustained clock was identified in the
cochlea, with ample circadian expression of core clock genes,
such as Per1, Per2, Bmal1, and Rev-erba, and persistent oscil-
lations of the PER2::LUC reporter ex vivo [23]. PER2 is abun-
dantly expressed in hair cells and spiral ganglion neurons, the
primary cells for auditory transmission [23]. A greater sensitivity
to night noise trauma was found compared to daytime and coin-
cided with a peak expression of Per2 at night [23]. What drivesust 5, 2019 ª 2019 The Author(s). Published by Elsevier Ltd. 2477
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Bmal1 Rev-erbα Hlf Tef Per2 Bmal1 Rev-erbα Hlf Tef Per2
Time <0,0001 <0,0001 0,0144 <0,0001 <0,0001 <0,0001 <0,0001 <0,0001 <0,0001 <0,0001
Light 0,2134 0,0579 0,6149 0,442 0,2788 0,0016 0,3378 0,0012 <0,0001 0,0586
SCN <0,0001 <0,0001 <0,0001 <0,0001 <0,0001 0,0003 <0,0001 <0,0001 <0,0001 <0,0001
Time x Light 0,2108 0,1867 0,9435 0,6549 0,072 0,0021 0,0665 0,0562 <0,0001 0,0396
Time x SCN <0,0001 <0,0001 0,0115 <0,0001 <0,0001 0,0005 <0,0001 0,0002 <0,0001 <0,0001
Light x SCN 0,7379 0,057 0,4789 0,4051 0,7601 <0,0001 <0,0001 <0,0001 <0,0001 <0,0001
Time x Light x SCN 0,2469 0,2311 0,3517 0,3711 0,1595 0,0008 <0,0001 0,001 <0,0001 <0,0001
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the cochlear rhythms and the differential sensitivity to noise
throughout the day remains unknown. In a series of pharmaco-
logical and surgical experiments, GCs have been shown to
modulate auditory function in response to noise insults [24, 25]
and thus could potentially integrate with the cochlear clock to
regulate the differential sensitivity to noise.
Here, we investigate whether BMAL1 and the SCN influence
cochlear clock rhythms and whether systemic cues, such as
GCs, regulate the differential day versus night noise sensitivity.
We hypothesize that GCs regulate cochlear clock rhythms on a
subset of circadian genes that may influence the vulnerability
to noise trauma at specific times of the day.
RESULTS
Cochlear Circadian Rhythms Are Dependent on Input
from the SCN
To directly determine whether the SCN is required for sustained
rhythmicity in the cochlea, we performed bilateral SCN electro-
lytic lesioning (SCNx), which is considered a reliable method to
demonstrate the control of the SCN over peripheral organs
[26]. Ablation of the SCN was confirmed by histology, various
metabolic measures (e.g., O2 consumption [VO2], respiratory ex-
change rate [RER], and food intake), and circadian locomotor ac-
tivity (Figures S1A–S1K). In the cochlea, the circadian expression
of clock and clock-controlled genes (i.e.,Bmal1, Per2,Rev-erba,
Hlf, and Tef) was abolished in SCNx samples in both LD and
dark/dark (DD) conditions. In contrast, the circadian rhythm of
these genes in the liver of SCNx animals was only abolished in
DD conditions (Figure 1A). Three-way ANOVA statistics reflected
these differences between the liver and the cochlea (Figure 1B).
This result suggests that, in contrast to the liver, light can entrain
the cochlear clock through signals from the SCN, as already
shown for the adrenal gland [9]. Interestingly, the effects on the
liver followed the regulation of fecal corticosterone (CORT),
which remained rhythmic in SCNx mice in LD, but not in DD cy-
cles (Figure S1L). These findings are consistent with previous re-
ports showing persisting fecal CORT secretion in behaviorally
arrhythmic Syt10:Cre;Bmal1(fx/fx) mice [27], unlike what is
known for blood CORT (most likely deriving from the adrenal
glands), which is completely arrhythmic in SCNx animals in LD
[6]. Consistent with the systemic adaptation to jet lag, qualitative
observations show the circadian pattern of cochlear mRNA tran-
scripts ofBmal1,Per2,Rev-erba, andRev-erbb to be inverted af-
ter 3 weeks in an inverted dark-light cycle, similar to what was
evidenced in the liver, a highly rhythmic circadian tissue used
as a control (Figure S1M).Figure 1. Effects of SCN Ablation on Clock Gene Expression in the Co
(A) Nanostring nCounter assays on cochlear and liver mRNA samples from sham (
LD cycles (open circles) and in DD cycles (filled diamonds). Values are expresse
(B) Summary statistics of the three-way ANOVA with circadian time (time), light
(a = 0.05).
(C) Peak phase time of PER2::LUC cochlear (blue) and liver (red) samples ex vivo
lower and upper quartiles shown as horizontal lines and the whiskers defining t
illustrated with the vertical dotted line, which is used as a reference point. Note t
(D) Periods of PER2::LUC cochlear (blue) and liver (red) samples are not affected
*p < 0.05; **p < 0.01; one-way ANOVA with Sidak’s post hoc analysis.
(E) Individual bioluminescent recordings from PER2::LUC cochleae (above) or liv
See also Figure S1.We next assessed the impact of SCN ablation on liver and
cochlear PER2 rhythms ex vivo (Figures 1C–1E) using PER2::
LUC transgenic mice [4, 28]. It is well known that placing an
organ in culture can reset its clock machinery, even when rhyth-
micity is lacking in vivo due to the lack of SCN input [26]. Consis-
tently, cochleas and liver from SCNx mice showed ample
rhythms ex vivo, even though no longer present in vivo (Figure 1).
Livers from SCNx mice placed in constant darkness (DD)
showed a high dispersion of phase times, with a phase advance
up to 5 h when compared to sham DD livers (p = 0.002; Figures
1C and 1E). In contrast, SCNx did not trigger phase differences in
the cochleae (p = 0.26; Figures 1C and 1E), and phase synchrony
was maintained. Period was not affected by either SCN ablation
or manipulation of light-dark cycle in both the cochlea (p = 0.885)
and liver (p = 0.319; Figure 1D). The phase differences in the liver
and the cochlea did not correlate with the period values (cochlea,
R2 = 0.0024, p = 0.879; liver, R2 = 0.1843, p = 0.184). Overall, our
results indicate that the influences of the SCN on the cochlea
differ from those on the liver.
The Cochlear Clock Requires Bmal1
BMAL1 function was deleted in the cochlea by using Pax2-Cre
mice (Pax2:Cre or Cre). As Pax2-Cre is also expressed in the fe-
male germline (A. Groves, personal communication), oocytes
were expected to contribute with an excised floxed allele, which
is thus deleted (D). Hence, homozygous Bmal1(fx/fx);Pax2:Cre
are referred as cBmal1(fx/D), carrying one constitutively deleted
allele and one floxed allele only targeted in Cre-expressing cells
(here, the cochlea). cBmal1(wt/wt) were used as controls. Acto-
grams confirmed that whole-body rhythmicity from cBmal1(fx/D)
was indistinguishable from controls in both LD and DD condi-
tions (Figure S2). We took advantage of the cBmal1(fx/D) mice
to cross them and obtain full cBmal1(D/D) mutants that served
as a positive control for the systemic loss of circadian rhyth-
micity. Similar to constitutive Bmal1 knockout (KO) mice [29],
cBmal1(D/D)micewere completely arrhythmic (Figure S2). Over-
all, the lack of systemic effects of the cBmal1(fx/D)mice allowed
us to investigate the effects of Bmal1 loss of function specifically
in the cochlea. Cochleae from cBmal1(fx/D) showed a rhythmic
PER2::LUC oscillation but with a rapid loss of rhythmicity, in
contrast to the SCN or the liver that kept sustained rhythmicity
(Figure 2). As what would be expected from mice constitutively
lacking Bmal1, cBmal1(D/D) confirmed the absence of PER2::
LUC rhythmicity in all organs (Figure 2). The rhythmic but damp-
ening PER2::LUC oscillations in cBmal1(fx/D), but not in
cBmal1(D/D), suggest that the cochlear clock is systems driven
and influenced by the input of other zeitgebers [30]. Thesechlea and the Liver In Vivo and Ex Vivo
black) and SCNx (red) mice collected every 6th hour around the clock in normal
d in relative percentage change (RPC). Values are mean ± SEM; n = 3.
/dark cycle (light), and SCN lesioning (SCN) as factors and their interactions
is shown as boxplots. The median value (vertical line inside the box) with the
he endpoints is shown. The average peak phase time of intact SCN in LD is
he sham-LD cochlea is significantly phase advanced in relation to the SCN.
by SCN lesioning or light-dark cycles. Results are mean values ± SEM; n = 4.
er (below) samples from sham LD, sham DD, or SCNx DD conditions.












































Figure 2. Cochlear-Specific Bmal1 Deletion (cBmal1) Abolishes
Circadian Rhythms in the Cochlea Ex Vivo
Representative bioluminescent traces from cBmal1;PER2::LUCmice showing
normal PER2::LUC oscillations in (wt/wt) cochleae, whereas these rapidly
dampen in the (fx/D) explants, but not in the liver or the SCN. cBmal1(D/D)
show complete loss of PER2::LUC rhythmicity in all tissues tested. See also
Figure S2.findings show that the cochlear clock relies on Bmal1 for main-
taining a self-sustained clock in absence of compensatory
mechanisms.
Glucocorticoid Depletion Protects the Cochlea against
Night Noise Trauma
We next evaluated the contribution of endogenous GCs, estab-
lished downstream mediators of SCN input [31], on day versus
night noise sensitivity and on circadian gene expression. A sur-
gical model of GC depletion (adrenalectomy [ADX]) was applied,
resulting in a loss of the circadian pattern of plasmaCORT in ADX
mice compared to sham-operated mice (p < 0.0001 at the peak
expression time; Figure 3A). We also confirmed the loss of
rhythmicity of Fkbp5, Lpin1, and Gk in the liver from ADX mice
(ANOVA for Sham and ADX data showed a significant effect of
group, p = 0.0003–0.0001, and a highly significant interaction be-
tween surgical condition and time of sample collection,
p < 0.0001, for the three genes; Figure 3B). These liver genes
have been shown to be most affected in their circadian rhyth-
micity after adrenalectomy [32].
To explore the influence of GCs on time-dependent auditory
function, we exposed animals to noise (6–12 kHz; 100 dB sound
pressure level [SPL] for 1 h) during daytime or nighttime. This noise
paradigm does not cause morphological changes to the outer
hair cells [23]. ADX did not affect the threshold shifts 24 h after
day (p = 0.47) or night noise exposure (p = 0.56; Figure 3C). How-
ever, 2 weeks after night noise exposure, ADX animals improved
their hearing at all frequencies when compared to sham-operated2480 Current Biology 29, 2477–2487, August 5, 2019mice that displayed persisting hearing loss (p < 0.0009; Figure 3A),
but a significant threshold shift of 7–16 dB remained. The day-
noise-exposed, sham-operated controls recovered, as did the
ADX mice (p > 0.83; Figure 3C), consistent with Meltser et al.
[23]. Wave 1 amplitudes of the auditory brainstem response
(ABR) were not altered at either 16 or 24 kHz or the wave 1/5 ratio
(data not shown). At the synaptic level, we found a similar
decrease in the number of ribbons after day or night noise expo-
sure at 3.4- and 4.5-mm distance from the apex when compared
to unexposed controls, but ADX did not rescue the loss of ribbons
(Figure 3D). Quantification of ribbon size did not reveal any differ-
ence among all groups across all frequencies (data not shown).
These findings suggest that the surge of GCs plays a significant
role in the vulnerability to noise trauma at nighttime, without
obvious morphological or functional effects on pre-synaptic
ribbons.
We next performed RNA sequencing (RNA-seq) on whole
cochleae collected 2 h after day or night noise trauma to inves-
tigate potential mechanisms involved in the regulation of noise
sensitivity by GCs. Using a generalized linear model (STAR
Methods), we identified 15 genes whose induction by noise
was significant at nighttime in sham-operated animals and was
abolished in cochleae from ADX mice (Figure S3; Table S1;
Data S1). These genes are involved in neurotransmitter signaling,
such asGabrd,Gabra6, andGrin2C, which have been previously
reported to have functional responses in the cochlea via GABA
and NMDA receptors [33, 34]. The induction of neuronal genes
that have shown their importance during auditory neuronal
development (i.e., Neurod1 and Neurod2) [35] was also sup-
pressed in ADX mice after night noise trauma (Figure S3).
Car4, which encodes the carbonic anhydrase 4, is abundantly
expressed in the lateral wall and in inner and outer hair cells
[36] and showed a similar gene expression pattern (Figure S3).
Additional genes were identified (Figure S3) but whose function
in the ear is presently unknown. On the other hand, ADX did
not prevent the induction of genes after day noise exposure.
Overall, our data indicate that GCs regulate a subset of genes
that are triggered only at nighttime and that ADX abolishes their
induction.
Glucocorticoids Regulate the Circadian Expression of
Inflammatory Genes in the Cochlea
To further explore the molecular mechanisms involved in the
circadian regulation of noise sensitivity, we performed RNA-
seq around the clock in sham-operated and ADX cochleae to
identify all the rhythmic genes under GC control. We next
applied a harmonic linear-regression-based model selection
approach on cochlear RNA-seq data that allows the clustering
of genes depending on their rhythmic or constant expression
patterns [37]. This approach assigned genes to one of five
models with distinct rhythmic patterns and phase specificity
(Figure 4A). Model 1 is composed of genes that are non-rhyth-
mic in ADX and sham conditions (7,174 genes); model 2 is
composed of non-rhythmic genes in sham cochleae that gained
rhythmicity after ADX (455 genes); model 3 identifies rhythmic
genes in both ADX and sham conditions (5,941 genes); model
4 consists of genes with altered rhythmicity after ADX (altered
phase and amplitude; 129 genes); and model 5 consists of




















B) ADX NADX D
24 h 2 w D






















Unexposed controls Unexposed controls
ADX



































0 4 8 12 16 20 0 4 8 12 16 20 0 4 8 12 16 20
ADXSham 





















Figure 3. Endogenous GCs Regulate Sensitivity to Night Noise Trauma without Influencing Synaptic Ribbons
(A) Plasma levels of circulating corticosterone (CORT) in sham-operated (open circles) and ADX (filled diamonds) mice every 4th hour across the circadian cycle.
(B) Nanostring nCounter assays show mRNA expression levels of three GC-dependent liver genes in sham (open circles) and ADX (filled diamonds) animals. All
values are expressed in relative percentage change (RPC) using CT 0 values as reference.
Values are mean ± SEM; n = 3–7 (A); n = 3 (B). *p < 0.05; **p < 0.01; ***p < 0.001; two-way ANOVA with Sidak’s post hoc analysis.
(C) ABR threshold shifts from sham-operated (open symbols) and ADX (filled symbols) mice exposed to noise at 9 a.m. (day, red circles) or at 9 p.m. (night, blue
diamonds) were measured 24 h (left panel) and 2 weeks (right panel) post-exposure. Results are mean values ± SEM; n = 5–8. *p < 0.05; **p < 0.01; ***p < 0.001;
two-way ANOVA with Bonferroni post hoc analysis. Stars depicted above sham-operated, night-noise-exposed group denote significance against sham-
operated, day-noise-exposed, whereas starts shown below indicate statistical significance between ADX night-exposed and sham-operated, night-exposed
mice.
(D) Quantification of synaptic ribbons along the cochleae of ADX (filled symbols) and shammice (open symbols) exposed to a day (left panel, red circles) or a night
(right panel, blue diamonds) noise trauma. Open black circles represent unexposed controls used as a reference. Results are mean values ± SEM; n = 2–7—with
the exception of n = 1 for some basal measurements. *p < 0.05; **p < 0.01; ***p < 0.001; one-way ANOVA with Sidak post hoc analysis for each frequency region.
See also Figure S3 and Table S1.(1,141 genes). This analysis revealed that the rhythmicity of
22.5% of the rhythmic genes depends on GCs (model 5; Fig-
ure 4B). Gene Ontology (GO) analysis of the five models using
PANTHER according to Mi et al. [38] is shown in Figure S4A.
To further examine these differences, we searched for over- or
under-representation of genes using a statistical overrepresen-
tation test (PANTHER; see STAR Methods for details). In model
2, we found an overrepresentation of genes related to RNA
metabolic processes and DNA-dependent transcription
(approximately 1.8-fold enrichment; Table S1). Genes in model
2 (gain of mRNA rhythmicity) were mainly related to transcrip-
tional processes. Model 4, which defines rhythmic genes with
altered phase and amplitude after ADX, was enriched in
clock-related genes (30-fold enrichment; Table S2; Figure S4B).
Genes in model 4 (rhythmic mRNAs but with altered properties)
were strongly associated with the circadian system and showed
a wide-range distribution of mRNA phases. Model 5 (loss of
rhythmicity) shows enrichment of genes related to the immune
system, suggesting that rhythmic genes under the control of
circulating GCs regulate circadian inflammatory responses in
the cochlea (see also Tables S2 and S3).Genes involved in the differential circadian regulation of noise
sensitivity were predicted to appear in model 5, whereby the
removal of circulating GCs would lead to the loss of circadian
transcription in the cochlea. A deeper GO analysis of model 5
identified genes encoding for defense and immune proteins,
immunoglobulin receptors, cell adhesion molecules, and extra-
cellular matrix proteins (Figure S4C; Table S3). GO analysis re-
vealed that biological processes related to the immune system
were the most enriched and included genes with a Bayesian in-
formation criterion weight (BICW) score >0.9 [37] with a clear loss
of rhythmicity in ADX conditions, such as cluster of differentiation
109 (Cd109) and C-C chemokine receptor type 2 and 9 (Ccr2 and
Ccr9; Figure 4C; Table S3). ANOVA then confirmed a significant
effect of group and time of sample collection (p < 0.02 in all
cases). With lower BICW scores, additional genes controlled
by circulating GCs belonging to GO terms, such as antibacterial
response, cytokine receptors, defense and immunity, immuno-
globulin receptor family, interferon family, and response to
stress, were found (Table S3). Overall, the results from the GO
analysis suggest that pro-inflammatory signals rise at nighttime




Figure 4. Transcriptomic Analysis of the Rhythmic Regulation of the
Cochlear Gene Expression by GCs
(A) Clustering of genes obtained from the RNA-seq depending on their
rhythmic or constant patterns of expression between sham and ADX condi-
tions and the corresponding number of genes. Model 1, constant mRNA levels
in both conditions; model 2, constant mRNA levels that became rhythmic in
ADX conditions; model 3, rhythmic mRNA levels in both conditions; model 4,
rhythmic transcripts that retained their rhythmicity but showed altered
2482 Current Biology 29, 2477–2487, August 5, 2019Differential Effects of Dexamethasone (DEX) on
Cochlear Rhythms and Noise Trauma
Thus far, the present data indicate that GCsmight be pro-inflam-
matory in the cochlea at nighttime, resulting in an increased
vulnerability to noise. This is counter-intuitive because it is rather
well established that DEX, a synthetic GR agonist, is protective
to the ear [24, 25]. However, all of these experiments were per-
formed during daytime, when the endogenous GC levels are
low. We therefore hypothesized that the effectiveness of DEX
on the cochlea may rely on the time of the day when adminis-
tered. We first examined the actions of DEX on cochlear PER2::
LUC rhythmswhen applied at trough or at peak PER2 expression
in presence or absence of forskolin pre-synchronization (Fig-
ure 5A), after selecting the optimal dose during day treatment
(Figure 5B). In absence of pre-synchronization, both day
and night treatment with DEX increased PER2::LUC amplitude
(p < 0.0001), but a phase advance was only observed at night
time (p = 0.049). No effects on the period were found (Figures
5C–5E). In order to differentiate the actions of DEX from its syn-
chronizing effects, we pre-synchronized cochleae using forsko-
lin 2 days after being placed in culture. Day treatment increased
the amplitude of the PER2::LUC rhythm by 60% (p = 0.0004),
whereas night treatment decreased the amplitude by 50%
(p = 0.01; Figure 5F). These findings illustrate that DEX has a dif-
ferential effect on the pre-synchronized cochlear rhythms, de-
pending on the time of the day. In pre-synchronized cochleae,
the phase was not affected after DEX treatment (Figure 5G),
whereas an increase in period was only found after night treat-
ment (Figure 5H). After day and night treatment, RU486, a GR
antagonist, blocked the effects of DEX; however, a decreased
amplitude change was found after day treatment (Figures S5A
and S5B). The reasons for these differences are not known. Spi-
ronolactone, a mineralocorticoid receptor (MR) antagonist, did
not alter the changes induced by DEX on cochlear clock rhythms
(p = 0.83; n = 3–12), further confirming the specificity of GR. We
used liver samples as a comparison and found that DEX had
no day or night effects on amplitude changes with or without
forskolin pre-synchronization (Figures S5C and S5F). However,
differential effects were seen on phase and period (Figures
S5D, S5E, S5G, and S5H). These findings illustrate that the
clocks from the cochlea and the liver respond differently to the
actions of DEX in presence or absence of pre-synchronization.amplitude and phase properties; and model 5, rhythmic transcripts that lost
their rhythmicity in ADX conditions are shown. Phase distribution of the five
different models is shown on the right panel.
(B) Expression heatmap for the gene groups showing rhythmic mRNA levels in
at least one of the conditions (sham operated or ADX). Mean relative expres-
sion of 3 biological replicates is shown (green, low levels; red, high levels).
Model 1 was excluded from the heatmap; none of the genes were circadian
and would result in a black area, yielding no information.
(C) Transcriptional profile of three putative GC-dependent circadian cochlear
genes from model 5, which were no longer rhythmic after adrenalectomy.
mRNA levels in sham-operated samples (open circles-dashed lines) and in
ADX samples (black diamonds-full lines).
All values are expressed in relative percentage change (RPC) using circadian
time (CT) 0 values as reference (n = 3). The horizontal axis shows CT. Values
are mean ± SEM; n = 3 (C). *p < 0.05; **p < 0.01; two-way ANOVA with Sidak’s
post hoc analysis.
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Figure 5. GC Protection against Noise
Trauma Correlates with Changes in the
Cochlear Clock Machinery
(A) Representative detrended bioluminescence
records of isolated PER2::LUC cochleae treated
with DEX at the trough (day, red) or at the peak
(night, blue) of oscillations. Forskolin synchroni-
zation was performed on day 3 at the rise of the
oscillations (black dashed line) before DEX
treatment. The time of forskolin treatment is
shown in dashed black lines.
(B) Dexamethasone dose response in PER2::LUC
amplitude changes from cochleas ex vivo ex-
pressed as a percent change from pre-treatment
values (treatment at 9 a.m.). 5 mM was selected
for subsequent treatments because it showed
significant increases in amplitude changes at
non-saturating levels.
(C–H) Quantification of PER2::LUC amplitude,
phase, and period change after DEX treatment of
cochleae in absence (C–E) or presence (F–H) of
forskolin pre-treatment (day, orange filled bars;
night, green filled bars). PBS treatment is shown
with hatched bars. Gray shaded areas indicate
the nighttime.
(I) Auditory threshold shifts of mice treated with
PBS (open symbols) and DEX (filled symbols)
exposed to noise at 9 a.m. (day, red circles) or at 9
p.m. (night, blue diamonds) and measured 24 h
post-exposure (left) and 2 weeks post-exposure
(right). For the sake of clarity, we only indicate the
statistics of DEX versus PBS groups for day or
night noise exposure, respectively.
Results are mean values ± SEM; n = 3–5 (A);
n = 5–6 (C–E); n = 8–21 (F–H); n = 5–11 (I).
**p < 0.01; ***p < 0.001; two-way ANOVA with
Bonferroni post hoc analysis. D, day; N, night.
See also Figure S5.The differential responses of the cochlear clock to day or night
DEX treatment ex vivo indicate that GC actions on the auditory
system might differ between day and night in vivo. To test this,
mice were treated with DEX 90 min prior to day or night noise
trauma. At 24 h post-exposure, the DEX day treatment protected
against noise damage compared to the day PBS-treated group
(DEX day, 12–18 dB; PBS, 29–34 dB; p < 0.01 for all frequencies
tested; Figure 5I). On the contrary, no effect of DEX treatment
was observed 24 h after night noise exposure (37–43 dB for
both DEX and PBS; p > 0.83 for all frequencies tested; Figure 5I).
2 weeks post-noise trauma, no differences were found between
PBS- and DEX-treated animals exposed during the day. Simi-
larly, DEX treatment did not improve the thresholds from animals
exposed to noise at nighttime. Still, the PBS day-exposed mice
showed lower threshold shifts than the night-noise-exposed an-
imals (ANOVA data showed a significant effect of group;Current Biop < 0.0001), confirming the differential
sensitivity to day and night noise injury
in the control animals. These findings
illustrate that the protective effects of
DEX occur when administered during
the day (when GC levels are low), with
significant changes seen 24 h post-noiseexposure, indicating time-specific effects of steroid treatment
against noise-induced hearing loss.
DISCUSSION
The present findings confirm that cochlear rhythms are controlled
byBmal1andsuggest this control issystemsdriven throughsignals
from the SCN. When Bmal1 is deleted in vivo in a tissue-specific
manner, a number of additional cues could contribute to a sus-
tained circadian clock. In absence of a functional BMAL1 in the
whole body, or in absence of the SCN, there are no more cyclic
cues todrivecellularclocks in vivo, and this is likelywhy thecochlear
rhythms become arrhythmic. Such hierarchical relationship be-
tween the SCN and the cochlea has never been evidenced before.
Interestingly, the influence of the SCNon cochlear rhythmsdiffered
from the liver, being associated with circulating CORT levels.logy 29, 2477–2487, August 5, 2019 2483
The ADX effect, which protected mice from hearing damage
following noise exposure at night, is a main result of this study.
Two hours after night noise exposure, cochlear genes such as
Gabra6, Gabrd, and Grin2c were upregulated in sham-operated
animals, but not in ADX mice. Grin2c transcripts, which encode
the NMDA receptor subunit 2C, are expressed in the rodent co-
chlea [33]. Because glutamate is considered as the main neuro-
transmitter between inner hair cells (IHCs) and afferent neurons
and that NMDA receptors are known to induce cochlear excito-
toxicity [39], it is possible that acute excitotoxicity contributes to
the reduced hearing thresholds observed 2 weeks after night
noise exposure. However, in spite of these clear molecular
mechanisms, our electrophysiological and morphological ana-
lyses of the inner hair cell and afferent neuron synapse did not
reveal any obvious change when assessed 2 weeks post-noise
exposure. It is possible that, in spite of significant molecular
changes, these may not have reached a sufficient amplitude to
cause morphological changes.
Wenote, however, that the ribbonquantification presented here
differs from that of our previous report [23], where a lower number
of synaptic ribbons were found in the apical region from sham-
exposed mice. The study from Meltser et al. relied on ImageJ
andmanual thresholding, whichmay have underestimated the rib-
bons from that region compared to the present study that uses
Imaris, resulting in a more accurate estimate of ribbon counts
and similar to what has been reported by Kujawa and Liberman
[40]. Meltser et al. showed a clear involvement of neurotrophins
in the vulnerability to night noise trauma, whereby activation of
the tropomyosin receptor kinaseB (TrkB) rescued the lossof hear-
ing after night noise trauma and partially recovered the amount of
ribbons lost [23]. Instead, the present findings show that ADX
partially rescues ABR thresholds from night noise trauma but
without altering the number of ribbons, suggesting that the GC-
mediateddifferential sensitivity to day and night noise trauma is in-
dependent from synaptic ribbon loss. Indeed, Yuan et al. showed
that >85% loss of IHC-afferent synapses is required to cause a
decreaseof >10 dB in the ABR thresholds. Our attempts to assess
synapse pairing (i.e., how many ribbons are paired with a post-
synaptic entity) using GluR2 antibodies failed, as the success of
this staining is variable and thus the status of functional synapses
in ADX model remains uncovered. Overall, these results indicate
that the differential sensitivity to noise throughout the day involves
additional mechanisms yet to be identified. For instance, this
could involve outer hair cell, spiral ganglion neuron, or lateral
wall function, which have not yet been explored.
The use of different models and mouse strains in the present
studysuggests that thedifferential sensitivity tonoise couldbeuni-
versal. However, differential day and night noise vulnerability has
never been tested in vivo in the PER2::LUC and cBmal1(fx/D)
mice from a C57BL/6J background. Recent studies suggest that
the circadian sensitivity to noise might not apply to all mice strains
and rodent species or to all types of noise trauma [41, 42]. Thus,
differences in timing (when and how long), intensity (low or high
noise levels), and genetic background may impact the outcome.
Indeed, our findings strongly support the involvement of GCs in
the circadian sensitivity to noise trauma. In this regard, the ampli-
tude of the circadian CORT profile is known to differ between rat
strains, stress levels, pathogenic conditions, and sex [43]. We
therefore hypothesize that the differential sensitivity to noise at2484 Current Biology 29, 2477–2487, August 5, 2019different times of the day may correlate with the amplitude of the
circadian CORT profile and the response to stress [43].
GCs are well-established downstreammediators of SCN input
[31]. Our data strongly suggest that GCs could be one of the key
signals that regulate sensitivity to noise at different times of the
day. It is interesting to discuss the role of GCs in the regulation
of pro-inflammatory signals within the cochlea together with the
recent finding, which showed the presence of immune cells
(mainly monocytes) in the cochlea of postnatal mice [44]. Mono-
cytes, which develop in the bone marrow, express CCR2 at their
surface andmigrate to sites of inflammation in response to CCL2
[45]. We found that mRNA expression of Ccr2 is rhythmic in the
whole cochlea, with an increase at nighttime 4 h after GC levels
have peaked in the plasma. Interestingly, GCs have been shown
to enhance the migratory capacity of monocytes [46] and regu-
late their secretion of the complement factor H [47], which we
also found to be rhythmic in the cochlea. Whether GCs trigger
greater mobilization of monocytes from the bone marrow during
nighttime or whether they influence monocytes known to patrol
tissue [48] is an interesting question. Sautter et al. revealed that
noise sensitivity and subsequent monocyte migration remains
unaffected in Ccr2 KO mice [49], suggesting that other factors
may compensate for CCR2 loss of function. It is also possible
that mice were exposed to noise during daytime, which could
have left the potential involvement of CCR2 in monocyte migra-
tion unrevealed. Indeed, monocytes also express in certain
conditions other chemokine receptors, such as CCR9 [50], which
encoding gene was also found circadian in the cochlea and
dependent on circulating GC levels. Thus, consistent with the
findings that Ccr2 and Ccr9 rhythmicity in the cochlea is abol-
ished after ADX, it is reasonable to speculate that GCs would
contribute to a greater migration of monocytes into the cochlea
after a noise trauma delivered at nighttime, which in turn would
have a negative impact on auditory recovery. The other possibility
is that GCs regulate the recruitment of other immune cells into the
cochlea. For instance, other cell types, like NK cells, NKT cells, or
T cells, are known to express CCR2 and CCR9 [51] and thus
could be recruited to the cochlea in a GC-dependent manner.
Our data thus suggest that GCs affect the transcriptional regula-
tion of inflammatory signals within the cochlea, but the RNA-seq
data from samples collected 2 h after noise trauma did not reveal
differentially regulated inflammatory signals between day and
night. It is possible that the chosen time point is not appropriate
to reveal such potential changes or that sampling the whole
cochlea dilutes more subtle effects occurring in sub-compart-
ments that could not be evidenced in the present study.
Nonetheless, the collected evidence strongly suggests that
mice aremore sensitive to noise trauma during the night because
GCs predispose the cochlea to inflammation. This contrasts the
known assumption that GCs would be beneficial to the auditory
system. There are indeed multiple findings in humans and
rodents, suggesting that GCs act on the hearing system tomodu-
late sensitivity to noise, either positively or negatively [24, 25].
Chronic stress has been shown to increase the susceptibility of
rats to noise trauma [52], whereas acute stress is protective
[53, 54]. Although it is established that chronic exposure to high
levels of circulating GCs is potentially harmful to the inner ear, it
is rather unexpected to find that the daily surge in GCs levels at
nighttime aggravates the cochlear response to noise. As a
consequence, changes in GCsmay result in completely opposite
fates in the vulnerability or resilience to noise trauma. Our former
studies on the protective effects of restrained stress on noise
trauma showed that auditory protection was achieved in the
same mouse strain during daytime when plasma CORT levels
were 2-fold higher than what was found in the present study at
nighttime [53, 54]. Such findings are in line with the well-estab-
lished non-monotonic dose responses commonly foundwith hor-
mones [55]. Thus, the effects of GCs on the cochlea appear to be
affected by dose, duration, and time of administration. A careful
evaluation of all these parameters may help to better understand
the actions of glucocorticoids on the inner ear.
The most commonly used agents to treat hearing disorders
are a class of GC steroids, such as DEX and prednisolone [56].
Here, the protective effects of DEX against noise trauma were
evidenced 24 h post-noise exposure and coincided when circu-
lating CORT levels were low. In contrast, the administration of
DEX at the time when circulating GCs were high did not protect
against noise trauma. One of the reasons for the differential pro-
tective response to DEX treatment against noise trauma could
stem from differences in local bioavailability in the cochlea due
to differences in the permeability of the blood labyrinth barrier,
as it happens in the brain [57]. Assuming that local DEX levels
are similar after day or night administration, GR activity might
thus differ depending on the time of the day. Such opposite fates
in DEX responses are illustrated by the different changes in
PER2::LUC amplitudes in cochlear explants, increasing when
cochleae are treated during daytime and decreasing when
treated during nighttime. In support of this hypothesis, the tran-
scriptional activity of GR is controlled in a circadian manner by
circadian regulators [13]. Thus, the anti-inflammatory actions of
DEX might prove ineffective, even though it has a high potency,
at the onset of night. Interestingly, the effects of DEX treatment
on amplitude and phase differed between the cochlea and the
liver. In the context of SCN ablations, our data also show differ-
ences between the two tissues in vivo and in vitro. These findings
indicate that the chronopharmacological actions of DEX could
likely differ, depending on the target tissue. Overall, in order to
achieve the desired effects of steroid treatment against noise-
induced hearing loss, the time of administration should be taken
under careful consideration. The inappropriate timing of steroid
administration against hearing loss could be grounds to the
mixed success described in clinical trials [58, 59].STAR+METHODS
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Chemicals, Peptides, and Recombinant Proteins
D-luciferin potassium salt Promega Cat# E1602
Forskolin Sigma-Aldrich Cat# F3917
Dexamethasone Sigma-Aldrich Cat# D-1159
RU486 (Mifepristone) Sigma-Aldrich Cat# M-8046
Spironolactone Sigma-Aldrich Cat# S-3378
Ketaminol (50 mg/ml) Intervet Cat# 511485
Rompun (20 mg/ml) Bayer A/S Cat# KP0A43D
Mouse Anti-CtBP2 (1:200) BD-Biosciences Cat# 612044; RRID: AB_399431
Rabbit anti-Myosin VIIa (1:200) Proteus Biosciences Cat#25-6790; RRID: AB_10015251
IgG2a goat anti-mouse AF488 (1:500) ThermoFisher Scientific Cat#A21131; RRID: AB_2535771
IgG donkey anti-rabbit AF647 (1:200) ThermoFisher Scientific Cat#557783; RRID: AB_2536183
IgG1 goat anti-mouse AF568 (1:500) ThermoFisher Scientific Cat#A21124; RRID: AB_2535766
TRIC-conjugated goat anti-mouse Jackson Immunoresearch Cat# 115-025-146; RRID: AB_2338488
Deposited Data
Gene Expression Omnibus https://www.ncbi.nlm.nih.gov/geo/ GEO: GSE107086 and GSE88954
Experimental Models: Organisms/Strains
Mouse: PERIOD2::LUCIFERASE transgenic
mice in a C57BL/6 background
[10] N/A
Mouse: Pax2Cre mice MMRRC Cat# 010569-Tg(Pax2-cre)1Akg/Mmnc
Mouse: Bmal1flox (Bmal1fx/fx) mice [60] N/A
CBA/CA/Sca mice Scanbur—*N.B. colony has




Lumicycle Analysis software Actimetrics http://www.actimetrics.com/products/lumicycle/
ClockLab Actimetrics http://www.actimetrics.com/products/clocklab/
Origin Software 8.1 SR1 Microcal Software http://www.originlab.com/
BioSigRP Tucker Davis Technologies http://tdt.com/downloads.html
ImageJ NIH https://imagej.nih.gov/ij/
GraphPad Prism 6 GraphPad software https://www.graphpad.com/
PANTHER GeneOntology http://www.pantherdb.org/
Other
Millicell membrane Millipore PICM0RG50
Corticosterone EIA kit Enzo Life Sciences Cat# ADI-900-097
Square Pulse Stimulator Grass Technologies Cat# S44B
Stimulus RF Transformer Isolation Unit Grass Technologies Cat # SIU5
Stereotaxic apparatus World Precision Instruments Cat# 502610
CLAMS Colombus Instruments N/A
Running wheels Med-Associates Cat# ENV-044
Confocal microscope Zeiss Cat# 710
ABR system Tucker Davis Technologies Cat# Sys3
RNAlater ThermoFisher Scientific Cat# AM7021
Direct-zol RNA MiniPrep Zymoresearch Cat# R2052
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REAGENT or RESOURCE SOURCE IDENTIFIER
Bioanalyzer Agilent Cat# 2100
Nanostring nCounter Nanostring technologies N/A
Qubit fluorimeter Life Technologies Cat# Q33216
HiSeq 2500 sequencer Illumina N/A
LumiCycle Luminometer Actimetrics LumiCycle 32LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact,
Christopher R. Cederroth (christopher.cederroth@ki.se).
This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All experimental procedures on animals were performed in accordance with the guidelines and regulations set forth by Karolinska
Institutet and ‘‘Stockholm’s Norra Djurförsöksetiska N€amnd’’ N370/12 and N156/14. CBA/CA/Sca mice, (from Scanbur) were
used for ADX and SCN studies. PER2::LUC (mPer2Luc) [4] and Bmal1(fx/fx) [61] mice were provided by Takahashi and Bradfield,
respectively. Pax-Cre (Pax:Cre) mice were obtained from the MMRRC (010569-Tg(Pax2-cre)1Akg/Mmnc). Bmal1(fx/fx) mice
(129SvJ 3 C57BL/6J N3 backcross) were crossed to Pax2:Cre (FVB) to produce we obtained homozygous Bmal1(fx/fx);Pax2:Cre
as well as heterozygous Bmal1(wt/fx);Pax2:Cre and wild-type Bmal1(wt/wt);Pax2:Cre control mice (all referred as cBmal1 mice).
We further crossed cBmal1(wt/fx);Pax2:Cre with PER2::LUC mice (Bmal1;Pax2:Cre;Per2Luc) in order to track PER2::LUC bio-
luminesence from cochlear explants in presence or absence of a functional BMAL1.
All mutants were genotyped at weaning (P21) from tail biopsies by classic PCR. For Bmal1 fx/fx mice, we used a set of 3 primers
[5436: 5-ccctgaacatgggaaagaga-3, 6013: 5-attcaccttttggggaggac-3, and 6014: 5-tcatcagaggaaccagggtaa-3] discriminating be-
tween Bmal1 wt (310 bp), Bmal1 fx (360 bp) and Bmal1 D (excised, 450 bp) alleles. For Pax2:Cre mice, we used a set of 2 primers
[F: 5-gcctgcattaccggtcgatgcaacga-3, 16026: 5-gtggcagatggcgcggcaacaccatt-3] amplifying a Cre band at 700 bp. For PER2::LUC
mice, we used a set of 3 primers [P1: 5-ctgtgtttactgcgagagt-3, P2: 5-gggtccatgtgattagaaac-3, and P3: 5-taaaaccgggaggtagatgaga-
3] discriminating between WT (230 bp), LUC (680 bp) alleles.
Males aged between 2 and 4 months, were used for audiological, morphological and molecular experiments. Animals had free ac-
cess water and to food (Lactamin R34, Lantm€annen). Food pellets contained 43mg/kg daidzin, 60 mg/kg genistin, 10 mg/kg glycitin,
2 mg/kg daidzein, 1.6 mg/kg genistein (Lantm€annen report). Temperature was maintained between 19 and 21C. The room lights
were on at 6 a.m. and off by 6 p.m. Handling in darkness was performed in red light.
METHOD DETAILS
Adrenalectomy
After being anesthetized with an i.p. injection of ketamine (100mg/kg) and xylazine (8 mg/kg), the adrenal glands were removed bilat-
erally through a dorsal midline incision and lateral retroperitoneal incisions. Following surgery, skin incisions were closed with sterile
wound clips and analgesia was provided for 48h (Temgesic, 0,02 mg/ml). Starting immediately after surgery, the drinking water was
replaced with 0.9% saline until the end of the experiments. Auditory threshold measures were started 2 weeks after surgery.
Corticosterone measurement
After decapitation under isoflurane anesthesia, trunk blood was collected in heparin coated tubes and placed on ice. Blood samples
were centrifuged at 1400 rpm, +4C, for 10 min and plasma was collected and placed on ice. Samples were treated with Steroid
Displacement Reagent (SDR, 6 mL plasma+ 6 mL SDR) and kept at +4C until further analysis. Feces were collected for 24 hours under
LD (12 h light/12 h darkness) or 3 days in DD (24 h darkness) conditions. Metabolic cages were used to minimize handling during
sample collection. Fecal collection was performed every 4th hour over 2 days. Collected samples were stored at –80C until ex-
tracted. Blood and fecal corticosterone levels were measured with EIA kits according to the manufacturer’s instructions (Corticoste-
rone EIA kit, Enzo Life Sciences, Farmingdale, NY).
Suprachiasmatic nucleus ablations
Bilateral lesions of the SCN were performed in a stereotaxic apparatus (World Precision Instruments, Sarasota, FL) under ketamine/
xylazine anesthesia (intraperitoneal injection, 80 and 14 mg/kg). A stainless steel insect pin (0.25 mm in diameter) was inserted at the
following coordinates: anteroposterior, +0.5 and +0.8 mm using the bregma as the reference; lateral, ± 0.25 mm; and depth,Current Biology 29, 2477–2487.e1–e6, August 5, 2019 e2
5.7 mm. SCN lesions were made using a electric stimulator (S44, Grass Technologies, Warwick, RI) and stimulus isolation unit
(SIU5, Grass Technologies). A 1.8 mA current was passed for 6 s. The sham lesioned mice underwent the same operation, but no
electric current was passed through the electrode.
To validate the lesions, SCN lesioned (SCNx) mice and sham operated mice were individually placed in the Comprehensive Lab-
oratory Animal Monitoring System cages (CLAMS, Columbus Instruments, Columbus, OH). After 24 h of acclimatization to the cages,
animals were kept in the system for a period of at least 4 consecutive days. Respiratory metabolism was analyzed with oxygen con-
sumption (VO2) and respiratory exchange rate (RER). Animal movements in the horizontal or vertical directions break the infrared
beams allowing for locomotor activity to be quantified [28]. The sum of any beam breakage in the horizontal direction was recorded
as ambulatory movement counts (XAMB). Food intake was also assessed. Metabolic parameters and activity were analyzed sepa-
rately for day (6 a.m. - 6 p.m.) and night (6 p.m. - 6 a.m.). To exclude partial lesioning of the SCN, brains of all operated mice were
coronally sectioned with 14 mm thickness and stained with cresyl violet. Images were analyzed in the region between0.22 mm and
0.82 mm, which is located caudally from the bregma along the rostro-caudal axis [62].
Actograms
To record the rhythm of locomotor activity, adult mice (at least 8-week old) were individually housed in activity wheel-equipped cages
(#ENV-044, Med-Associates, St Albans City, VT) under LD 12:12 for at least 24 days. Locomotor activity was recorded using Wheel
Manager sofware (#SOF-860, Med-Associates, St Albans City, VT) and analyzed using ClockLab software (Actimetrics, Wilmette, IL).
Fluorescent lights (300–600 lux inside the cage) were used for behavior experiments. Mice were transferred into DD for 2 weeks.
Wheel-running activity was recorded and analyzed. The free-running periods in DD and LL were calculated using c2 periodogram
analysis (Clocklab software, Actimetrics). The amplitude of circadian rhythm was analyzed using the fast Fourier transform (FFT),
which estimates the relative power of approximately 24 hr period rhythm in comparison with all other periodicities in the time-series.
The power spectral densities for frequencies ranging from 0 to 1 cycle/hr were determined and normalized to a total power (area un-
der the curve) of 1.0. The peak in the circadian range (18- to 30-hr period or 0.033–0.055 cycles/hr) of the relative power was deter-
mined for each animal for comparison. If no significant periodicity in the 18–30 hr range was detected by FFT, the free-running
period could not be scored. For the analysis of total daily activity, the total number of wheel revolutions per day was averaged in
LD (7 first days of initial LD interval excluded) and DD.
Organotypic cultures
Adult cochleae, suprachiasmatic nucleus (SCN) and livers were dissected from PER2::LUC mice and cultured organotypically on a
membrane (Millipore, PICMORG50) as described previously [23, 28]. Cochleae, dissected free of bone and stria vascularis, were kept
in culture for minimum 6 days and its morphology characterized [63]. Isolated cochleae from PER2::LUC mice (6-8 weeks of age)
were used. The bioluminescence emission from the cochlea was measured for a duration of 1 min every 10th minute with Lumicycle,
a microplate luminometer equipped with photomultiplier tubes (Actimetrics, Wilmette, IL). Parameters of PER2::LUC rhythmicity
(period, amplitude and phase) were analyzed using Origin software 8.1 SR1 (Microcal Software, Northampton, MA, USA). Data
from each recording trace was first normalized by subtracting the 24 h baseline drift from the raw data. The amplitude was calculated
as the difference between highest (peak) and lowest (trough) photon count within one cycle. The calculation was performed from
trough-to-peak and from the peak-to-trough, thus giving two values (half-cycles) within one cycle. For each amplitude data point,
three half-cycles (1.5 cycle) were used for amplitude analyses. The very first peak after culture start was not used. Phase was deter-
mined as maximum (peak) luminescence between 24 and 48 hours (peak between day 1 and 2) of recording. The average peak time
of each treatment groupwas calculated and statistically comparedwith the respective shamgroup. The period of one complete cycle
was defined as the time between two consecutive peaks (i.e., the highest photon count within one cycle) and five consecutive peaks
were used for averaging periods.
Drug treatment in vivo and in vitro
Ninety min prior to noise trauma, mice were given a 4 ml/kg intraperitoneal injection of 0.5 mg/kg Dexamethasone phosphate diso-
dium salt (DEX, Sigma Aldrich, D1159) dissolved in vehicle (PBS solution). For in vitro treatments, we used 5 mM DEX dissolved in
PBS, 50 mM Forskolin (Sigma Aldrich, F3917) dissolved in DMSO, 25mM Mifepristone (RU-486, Sigma Aldrich, M8046) dissolved
in PBS or 5mMSpironolactone (Sigma Aldrich, S3378) dissolved in ethanol. PER2::LUC rhythms (amplitude and phase) were analyzed
using Origin software 8.1 SR1 (Microcal Software) and period was analyzed by using the Lumicycle Analysis program fromwhere we
extracted the raw data. Data from each recording trace was first normalized by subtracting the 24h baseline drift from the raw data.
The amplitude was calculated as the difference between the highest (peak) and the lowest (trough) photon count within one cycle.
The calculation was performed from trough to peak and from peak to trough which gave two values (half-cycles) within a cycle. For
each amplitude data point, 3 half cycles (1.5 cycles) were used for amplitude analyses. The 3 half-cycle amplitudes were then aver-
aged in order to give themean absolute amplitude over the selected 1.5 cycle period before and after treatment for each sample. The
percentage of the amplitude change between pre-treatment and after treatment period was calculated at the end. The very first peak
after culture beginning was not used. Phase was determined as the highest (peak) luminescence at around 48 hours (peak at day 2)
after the start of the PER2::LUC recording of the tissue. Phase shifts were calculated in order to observe the drug effect. Phase shifts
were calculated by subtracting the second peak before treatment from the first post-treatment peak, which was 12h after the
trough treatment or 24h after the peak treatment. Period of one complete cycle was defined as the time between 2 consecutive peakse3 Current Biology 29, 2477–2487.e1–e6, August 5, 2019
(the highest photon count within one cycle). In order to define the period after treatment, more than 2 consecutive cycles were
selected.
Acoustic trauma and auditory brainstem response (ABR)
To generate hearing loss, awake animals were treated with free field broadband noise at 6 - 12 kHz at intensity of 100 dB SPL for 1 h,
similar to previously described noise trauma paradigm [23], at either 9 a.m. or 9 p.m. After being anesthetized with an i.p. injection of
ketamine (100 mg/kg) and xylazine (10 mg/kg), auditory sensitivity was assessed with ABR thresholds for the frequency of 8, 12, 16
and 24 kHz as previously described [23]. Post-traumameasurements were performed 24h and 2 weeks after day or night exposures.
Threshold shifts were determined by subtracting baseline hearing thresholds from post-exposure thresholds.
Immunocytochemistry and quantification of synaptic elements
For immunostaining, mice underwent transcardiac perfusion with 4% paraformaldehyde in phosphate-buffered saline (PBS) and
cochleae were decalcified in EDTA 2% for 2-3 days. For the quantification of synaptic ribbons and synapses, surface preparations
were stained for C-terminal binding protein 2 (mouse (IgG1) anti-CtBP2, 612044 from BD-Biosciences, used at 1:200), to quantify
pre-synaptic ribbons and rabbit anti-Myosin VIIa, 25-6790 from Proteus Biosciences, used at 1:200 to delineate the hair cell bodies.
Primary antibody incubations were performed overnight at 37oC, followed by 60-min incubations at 37oC with secondary antibodies
coupled to Alexa fluor dyes (IgG1 goat anti-mouse AF568 at 1:500 and IgG donkey anti-rabbit AF647 at 1:200), correspondingly. The
cochlear pieces were mounted in Vectashield, coverslipped and sealed with nail polish. Cochlear frequency mapping was then per-
formed using a custom plug-in to ImageJ from NIH (Measure_Line.class from the Liberman laboratory at the Eaton-Peabody Labo-
ratory). This gave the total length of the cochlea and their respective frequency points and was used as a guide obtaining confocal
images for discrete frequency regions along the length of the cochlea. Confocal z stacks along discrete regions of the basilar mem-
braneweremadewith a 63x oil immersion objective (N.A.1.40) on a Zeiss LSM710 confocal microscope. A z-step-size of 642 nmwas
used to capture all synaptic structures of at least 10 hair cells. Image stacks were analyzed using Imaris software (x64 9.1.2, Bitplane
AG, Zurich, Switzerland) for the number of ribbons as well as their volume. For assessing the total number of ribbons, surface and
masking properties were identified. Then the region of interest (approximately 10 hair cells) was tagged for counting by using the
‘’spots’’ function. After adjusting for the thresholds, puncta with pixel intensities greater than 0.7 um on an 8 bit scale (0-255)
were counted. The volume of each puncta was determined by using different spot sizes function. Then the same procedure as for
the number of puncta was followed in order to specify the size. The group a sample belonged to was blinded to the analyst.
mRNA extraction
To assess molecular changes in absence of entrainment, animals were placed three days in darkness (free running conditions), and
decapitated under isoflurane anesthesia and organs were collected. RNA extraction was performed as previously described with
slightmodifications [64]. Cochleaewere stored in RNAlater for 18-24 hours at 4Cprior to extraction with the Direct-zol RNAMiniPrep
kit from ZymoResearch, without phase-separation (Nordic Biolabs AB, Sweden). DNase treatment was performed on-column as rec-
ommended by the manufacturer. RNA integrity was assessed using RNA 6000 nanochips with an Agilent 2100 bioanalyzer (Agilent
Technologies, Palo Alto, CA) and quantity was evaluated with Nanodrop. Average 260/280 ratios were 2.05 ± SD 0.04, 260/230 ratios
were 2.39 ± SD 0.39, RIN was 9.2 ± SD 0.13, and 18/28S was 2.12 ± SD 0.13.
Quantitative evaluation of mRNA transcripts
NanoString nCounter measures of mRNA transcript abundance has been validated against SybrGreen qRT-PCR assays in previous
work on bacteria (R = 0.98 to 0.99) and in the cochlea (R = 0.9826 for Per2 transcripts around the clock). NanoString nCounter assays
were performed with 100 ng total RNA from 3-4 biological samples collected every 4 or 6 h around the clock as previously described
[28]. Probes for the analysis were synthesized by Nanostring technologies. After probe hybridizations and Nanostring nCounter dig-
ital reading, counts for each RNA species were extracted, analyzed using a homemade Excel macro, and then expressed as counts
(molecules of mRNA/sample). Barcodes were counted for – 1150 fields of view per sample. Background correction was done by sub-
tracting themean + 2 standard deviations of the negative controls for each sample. Values < 1were fixed to 1. The nCounter CodeSet
contained two types of built-in controls: positive controls (spiked RNA at various concentrations to assess the overall assay perfor-
mance), and negative controls (alien probes for background calculation). Data handling and analysis was performed as described:
background correction consisted of the subtraction of the negative control average plus two SD from the original counts.
To select adequate normalization genes from a series of candidates included in the CodeSet, their relative stability was evaluated
using geNorm-method. For the final normalization of the sample values the geometric mean of the counts obtained from 6 normal-
ization genes was calculated and used as normalization factor. Normalized quantities were averaged for three technical replicates for
each data point and represented as the mean ± SD. The highest normalized relative quantity was arbitrarily designated as a value of
1.0. Fold changes were calculated from the quotient of means of these normalized quantities and reported as ± SEM.
RNA-sequencing
Total RNA was quantified with a Qubit fluorimeter (Life Technologies) and RNA integrity assessed with a Bioanalyzer (Agilent Tech-
nologies). The TruSeq mRNA stranded kit from Illumina was used for the library preparation with 300 ng of total RNA as input. Library
molarity and quality was assessed with the Qubit and Tapestation using a DNAHigh sensitivity chip (Agilent Technologies). Pools of 6Current Biology 29, 2477–2487.e1–e6, August 5, 2019 e4
libraries were loaded at 8.5 pM for clustering on a Single-read Illumina Flow cell. Reads of 50 bases for the noise experiment, or 100
bases for the around the clock experiment, were generated using the TruSeq SBS HS v3 chemistry on an Illumina HiSeq 2500
sequencer. Quality Control (QC) was done with FastQC v.0.11.5. Reads were mapped with TopHat2 v.2.0.11. Biological QC was
done with PicardTools v.1.141. Reads per gene feature were counted with HTSeq v.0.6p1. Normalization was performed according
to the design model with R/Bioconductor edgeR v. 3.4.2.
Noise exposure RNA-seq analysis
Three replicates for each group of animals exposed to sham noise (Sh) or noise during day (DN) or nighttime (NN), ADX or sham ADX
(ShADX) [ShDNShADX, DNShADX, ShDNADX, DNADX, ShNNShADX, NNShADX, ShNNADX, NNADX], andwere renamedGroup 1 to
8 (Table S1) and whose cochlear tissue was collected 2h post-noise exposure were used and in total 38 samples were subjected to
RNaseq. Sequencing of each replicate generated 34.7 million reads of which approximately 94% were uniquely mapped to the
mouse genome and on average 27million reads (79.82%) were uniquely mapped to known exons, allowing for gene expression level
estimates.
The differential expression analysis was performed with the statistical analysis R/Bioconductor package edgeR v. 3.14.0. Briefly,
the counts were normalized according to the library size and filtered. The genes having a count above 1 count per million reads (cpm)
in at least 3 samples were kept for the analysis. The differentially expressed genes tests were done with a GLM (generalized linear
model) with a negative binomial distribution. The raw gene number of the set is 23’420. The poorly or not expressed genes were
filtered out. The genes expressed with least at 1 cpm (count per million reads) in 3 samples are kept. The differentially expressed
genes p values are corrected for multiple testing error with a 5% FDR (false discovery rate). The correction used is Benjamini-Hoch-
berg (BH). The filtered dataset consists of 15’580 genes. Of note, one of the samples of the ShDNShADX condition appeared as an
outlier in a majority of genes and therefore was excluded from Figure S3 for visualization purposes, although it has been included in
the statistical analysis (Data S1).
Temporal RNA-seq analysis
Three replicates for each time point (CT0, CT4, CT8, CT12, CT16 and CT20) were used and in total 36 samples were subjected to
RNaseq. Sequencing of each replicate generated 33 million reads. Reads were mapped to the mouse reference genome
(GRCm38/mm10) [65] using STAR 2.3.8 [66]. From all reads per sample, 86.8% to 89.2% were uniquely mapped to the genome;
9.1%–11.3% aligned to multiple loci in the genome. A custom Perl script was used to count the uniquely mapped reads for each
gene (for details see [37]). The yielded count data was normalized by the size factor according to [67]. For downstream analysis
such as rhythmicity assessment, visualization and clustering a variance stabilizing transformation was applied to the normalized
reads.
In order to extract genes differentially expressed between ADX and sham operated mice, we used DESeq2 [67] available from
the Bioconductor open development software project. For each gene, normalized counts were fit to a generalized linear model
(time + condition), where condition is the factor of interest (levels: ADX and sham operated) and time represents the different
time points of the sampling (levels: CT0, CT4, CT8, CT12, CT16 and CT20). A likelihood ratio test (LRT) was subsequently applied
to compare the full model with a reduced model that only includes the time factor.
In order to extract rhythmicity in gene expression of ADX or sham operated mice we applied a multiple linear regression to the
data followed by a subsequent Bayesian information criterion (BIC) based model selection as described in detail elsewhere [68].
Briefly, we defined the equation y(t) = m + acos((2p/24 h)t) + bsin((2p/24 h)t) + noise (where, y is the vsn stabilized expression levels
for each gene, m is the mean, t represents circadian time, a and b are the coefficients). To assess rhythmicity we defined 5 models
for the two conditions (ADX and sham operated). The models differ in their value for the coefficient a and b. These coefficients
determine amplitude and phase. A coefficient that is zero indicates a non-rhythmic pattern while non-zero values indicate a rhyth-
mic pattern. Moreover, we allowed a and b to be the same for selected models for both conditions. The resulting models are
defined as: Model 1 that comprises genes, which show no rhythmicity in either condition; model 2 contains genes that show rhyth-
micity in ADX mice only: genes that belong to model 3 show rhythmic profiles only in sham operated animals. Models 4 and 5
contain genes that are rhythmic in both conditions.While inmodel 5 the rhythmic parameters for amplitude and phase are different,
genes categorized into model 4 share the same parameters between the two conditions. Linear regression was applied to solve all
models, the model complexity was subsequently controlled by a Bayesian information criterion (BIC) based model selection
(https://www.tandfonline.com/doi/abs/10.1080/01621459.1995.10476572). BIC penalizes for model complexity. We considered
the resulting Schwarz weight to assess the confidence of a model and have chosen the model with the highest weight to describe
the rhythmic properties. Gene expression patterns where the model selection did not reach a BIC weight (BICW) above 0.4 were
categorized as ‘‘ambiguous.’’ To prove that type-I like errors (false positive) are controlled using this approach, we randomly per-
mutated the time points within each condition of the entire RNA-Seq dataset (ADX and sham operated). The median of the ratio of
type-I errors in 100 different permutations among all tested genes was 4.73% and 5.62% for ADX and sham operated, respec-
tively. Given that rhythmic genes can vary quite strongly in gene expression between different time points, some of the permuta-
tions still might represent slightly rhythmic gene profiles for some genes and the given median is rather an overestimation. In line
with this thought, at an amplitude threshold of log2fc of 0.2 the median of type-I like errors is 0.57% and 1.07% for ADX and sham
operated, respectively.e5 Current Biology 29, 2477–2487.e1–e6, August 5, 2019
Gene ontology analysis
Gene ontology analysis was performed with the ontology-based PANTHER (protein annotation through evolutionary relationship)
classification system (http://www.pantherdb.org/) according to instructions [38].
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical information can be found in the figure legends of every experiment and in the respective section of the methods. If not
stated otherwise statistical tests were performed in GraphPad Prism 6 (GraphPad Software, CA, USA). Where possible, all data
points are shown along with mean values ± SEM unless otherwise noted. The significance level for statistical testing was set at
0.05. Reported N are the number of animals/samples analyzed.
DATA AND CODE AVAILABILITY
The RNA-Seq datasets generated during this study are available at Gene Expression Omnibus (GEO: GSE107086 and GSE88954,
http://www.ncbi.nlm.nih.gov/geo/).Current Biology 29, 2477–2487.e1–e6, August 5, 2019 e6
